Imunon, Inc.
IMNN
$1.98
-$0.04-1.98%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 12.41% | 2.32% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 22.61% | 25.58% | |||
| Operating Income | -22.61% | -25.58% | |||
| Income Before Tax | -23.15% | -25.12% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -23.15% | -25.12% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -23.15% | -25.12% | |||
| EBIT | -22.61% | -25.58% | |||
| EBITDA | -23.11% | -26.28% | |||
| EPS Basic | -23.91% | 37.57% | |||
| Normalized Basic EPS | -23.90% | 37.57% | |||
| EPS Diluted | -23.91% | 37.57% | |||
| Normalized Diluted EPS | -23.90% | 37.57% | |||
| Average Basic Shares Outstanding | -0.61% | 100.42% | |||
| Average Diluted Shares Outstanding | -0.61% | 100.42% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||